MedGenome (MEDGENOME IN)

The company develops and operates a genomics-based diagnostics and research platform for patients, pharmaceutical companies, and research institutions. The firm applies bioinformatics and big data analytics to understand the genetic basis of cancer, metabolic disorders, and rare diseases, while providing genetic diagnostic tests for immuno-oncology, infectious diseases, and reproductive health to support drug development and clinical insights.